Efficacy of text messaging in improving care for psoriasis patients

Not Applicable

• Conditions: Psoriasis; Cardiovascular - Coronary heart disease; Metabolic and Endocrine - Metabolic disorders; Diet and Nutrition - Obesity; Skin - Dermatological conditions; Inflammatory and Immune System - Autoimmune diseases; Public Health - Health service research

• Registration Number: ACTRN12624000498594
• Lead Sponsor: Western Sydney Local Health District

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2024-04-23
• Last Update Posted: 29 April 2024

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Participants must meet ALL of the following inclusion criteria:
•Aged 18 years or older
•Have documented evidence of a diagnosis of psoriasis (chronic plaque type) by a dermatologist
•Have an active mobile phone, that can receive text messages, with internet access (to be able to access educative links via text-messages)
•Proficiency of the English language to consent and read text messages
•Willingness and ability to provide informed consent and willingness to participate and comply with the study requirements.

Exclusion Criteria

•Unable to follow up for the duration of the study due to frailty, geographical, physical or social reasons
•Pregnant/Lactating women
•Recent myocardial infarction, unstable angina or stroke (< 3 months)

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Change in Patient Activation [PAM-13 (Patient Activation Meaure) score Baseline and 26 weeks post baseline (appproximately 6 months)]